Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of Bcl-2 Inhibitor Sonrotoclax (BGB-11417) in Participants With Mature B-Cell Malignancies	Mature B-Cell Malignancies	Active, not recruiting	Phase 1	2026-06-22		NCT04277637

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
BeOne Medicines	76

43 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Auckland City Hospital	Auckland	New Zealand	68
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda	Milan	Italy	24
Azienda Unita Sanitaria Locale Di Ravenna	Ravenna	Italy	2
Box Hill Hospital	Box Hill	Australia	2
Centroricerche Cliniche Di Verona Srl	Verona	Italy	4
Columbia University Medical center	New York	United States	224
Concord Repatriation General Hospital	Concord	Australia	11
Flinders Medical Centre	Bedford PK	Australia	5
Fondazione Policlinico Universitario Agostino Gemelli	Roma	Italy	25
Fred Hutchinson Cancer Research Center	Seattle	United States	10
Hospital Clinic de Barcelona	Barcelona	Spain	137
Hospital de La Santa Creu I Sant Pau	Barcelona	Spain	96
Hospital Universitario de Salamanca	Salamanca	Spain	47
Hospital Universitario Marques de Valdecilla	Santander	Spain	29
Ico H Duran I Reynals	Barcelona	Spain	2
John Flynn Private Hospital	Tugun	Australia	2
John Theurer Cancer Center Hackensack University Medical Center	Hackensack	United States	8
Linear Clinical Research	Nedlands	Australia	14
Massachusetts General Hospital	Boston	United States	1015
Mayo Clinic Rochester	Rochester	United States	9
Md Anderson Cancer Center	Houston	United States	8
Memorial Sloan Kettering Cancer Center Mskcc	New York	United States	11
Monash Health	Clayton	Australia	16
North Shore Hospital	Auckland	New Zealand	15
Northwestern University	Chicago	United States	727

Clinical trials